| Date Filed | Type | Description |
| 06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2020 |
4
| Scadden David (Director) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 11,538 options to buy
@ $27.49, valued at
$317.2k
|
|
| 06/09/2020 |
4
| Scadden David (Director) has filed a Form 4 on Magenta Therapeutics, Inc.|
Txns:
| Granted 18,188 options to buy
@ $9.99, valued at
$181.7k
|
|
| 06/01/2020 |
4
| Scadden David (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Granted 8,096 options to buy
@ $53.35, valued at
$431.9k
Granted 1,686 restricted stock units
@ $0
Exercised 1,878 restricted stock units
@ $0 |
|
| 06/11/2019 |
4
| Scadden David (Director) has filed a Form 4 on Magenta Therapeutics, Inc.|
Txns:
| Granted 18,188 options to buy
@ $13.4, valued at
$243.7k
|
|
| 05/31/2019 |
4
| Scadden David (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Granted 8,919 options to buy
@ $47.91, valued at
$427.3k
Granted 1,878 restricted stock units
@ $0
Exercised 1,400 restricted stock units
@ $0 |
|
| 02/07/2019 |
4
| Scadden David (Director) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 23,076 options to buy
@ $21.14, valued at
$487.8k
|
|
| 02/07/2019 |
3
| Scadden David (Director) has filed a Form 3 on Editas Medicine, Inc. |
| 06/27/2018 |
4
| Scadden David (Director) has filed a Form 4 on Magenta Therapeutics, Inc.|
Txns:
| Converted 28,076 shares
@ $0
Bought 6,600 shares
@ $15, valued at
$99k
Converted 50,025 preferred shares
@ $0
Converted 6,429 preferred shares
@ $0
Converted 16,094 preferred shares
@ $0 |
|
| 06/20/2018 |
3
| Scadden David (Director) has filed a Form 3 on Magenta Therapeutics, Inc. |
| 06/04/2018 |
4
| Scadden David (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Granted 5,700 options to buy
@ $93.5, valued at
$533k
Granted 1,400 restricted stock units
@ $0 |
|
| 03/20/2018 |
4
| Scadden David (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Bought 200 shares
@ $83.44, valued at
$16.7k
|
|
| 06/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |